Related Experiment Video
Updated: Jul 3, 2026

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
Published on: December 4, 2021
Maggots do not survive in pyoderma gangrenosum
Regina Renner1, Regina Treudler, Jan C Simon
1Department of Dermatology, Venereology and Allergology, Universitätsklinikum Leipzig, Leipzig, Germany. regina.renner@medizin.uni-leipzig.de
Abstract:
Application of maggots is well established in wound therapy. We report upon 2 patients with leg ulcers due to pyoderma gangrenosum who received immunosuppressive therapy and in whom a reduced survival of maggots (Lucilia sericata sp.) led to ineffectiveness of this therapy.
Insights
Maggots are used in wound therapy, but their effectiveness can be reduced. In two patients with pyoderma gangrenosum leg ulcers on immunosuppressive therapy, reduced maggot survival led to treatment failure.
Area of Science:
- Medical and Veterinary Entomology
- Dermatology
- Wound Healing Research
Background:
- Maggot therapy, utilizing species like Lucilia sericata, is a recognized treatment for chronic wounds.
- Pyoderma gangrenosum is a severe inflammatory skin condition often requiring immunosuppressive treatment.
- Effective wound management is crucial for patient outcomes and quality of life.
Observation:
- Two patients with pyoderma gangrenosum leg ulcers were treated with maggot therapy.
- These patients were concurrently undergoing immunosuppressive therapy.
- A reduced survival rate of Lucilia sericata maggots was observed in these patients.
Findings:
- The reduced survival of maggots (Lucilia sericata sp.) compromised the efficacy of maggot therapy.
- Immunosuppressive therapy may negatively impact the viability of maggots used in wound treatment.
- This led to an overall ineffectiveness of the maggot application in these specific cases.
Implications:
- Clinicians should consider potential interactions between immunosuppressive drugs and maggot viability in wound care.
- Further research is needed to understand and mitigate factors affecting maggot survival during therapy.
- Alternative or adjunctive wound care strategies may be necessary for patients on immunosuppressive therapy with pyoderma gangrenosum.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Staphylococcal Skin Infections
Peptic Ulcer Disease II: Pathophysiology
Bacterial Phylum Tenericutes
Bacterial Phylum Spirochaetes